Tela Bio Inc Expected To Post A Loss Of 55cents A Share: Earnings Preview

TELA Bio

18/03/2022 21:42

* TELA Bio Inc  TELA.OQ   TELA.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 21. 
    * The Malvern Pennsylvania-based  company is expected to
report  a
40.8% increase in revenue to $7.977 million from $5.67 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TELA Bio Inc is for
a
loss of 55 cents per share. For the same quarter last year, the
company reported a loss of 54 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$19​, above​ its last closing price of $11.98. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.54       -0.52      -0.57     Missed  -8.6
 Jun. 30 2021  -0.53       -0.52      -0.57     Missed  -9.6
 Mar. 31 2021  -0.49       -0.48      -0.56     Missed  -16.1​
 Dec. 31 2020  -0.42       -0.49      -0.54     Missed  -10.7
 ​​Sep.        -0.49       -0.49      -0.53     Missed  -9.2
 30 2020                                                
 Jun. 30 2020  -0.59       -0.59      -0.53     Beat    9.8​
 Mar. 31 2020  -0.56       -0.56      -0.63     Missed  -12
 Dec. 31 2019  -0.58       -0.59      -1.22     Missed  -105
 This summary was machine generated March 18 at 21:42 GMT.  All
figures in US dollars  unless otherwise stated